Does Dexmedetomidine Decrease the Incidence of Untoward Airway Events After Deep or Awake Extubation in Patients Undergoing Adenotonsillectomy With or Without Myringotomy and Tube Placement?
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Adverse reactions
- 01 Oct 2015 Planned End Date changed from 1 Apr 2016 to 1 Feb 2018 as reported by ClinicalTrials.gov record.
- 01 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Feb 2018 as reported by ClinicalTrials.gov record.
- 11 Mar 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 Oct 2015.